Education
About Us
Working with TipRanks
Follow Us
THC Farmaceuticals Inc (CBDG)
OTHER OTC:CBDG
Total Valuation
THC Farmaceuticals has a market cap or net worth of $384.39K. The enterprise value is ―.
Market Cap$384.39K
Enterprise Value―
Share Statistics
THC Farmaceuticals has 18,131,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,131,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
THC Farmaceuticals’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -0.55%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-0.55%
Return on Capital Employed (ROCE)-0.01
Revenue Per Employee0.00
Profits Per Employee-7.49K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of THC Farmaceuticals is ―. THC Farmaceuticals’s PEG ratio is 0.12.
PE Ratio―
PS Ratio0.00
PB Ratio0.06
Price to Fair Value0.06
Price to FCF0.29
Price to Operating Cash Flow0.66
PEG Ratio0.12
Income Statement
In the last 12 months, THC Farmaceuticals had revenue of 0.00 and earned -14.98K in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-4.95K
Operating Income-29.95K
Pretax Income-29.95K
Net Income-14.98K
EBITDA-25.00K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -14.99K and capital expenditures 0.00, giving a free cash flow of -14.99K billion.
Operating Cash Flow-14.99K
Free Cash Flow-14.99K
Free Cash Flow per Share>-0.01
Dividends & Yields
THC Farmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-13.27
52-Week Price Change700.00%
50-Day Moving Average0.02
200-Day Moving Average―
Relative Strength Index (RSI)76.32
Average Volume (3m)1.13K
Important Dates
THC Farmaceuticals upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
THC Farmaceuticals as a current ratio of 0.12, with Debt / Equity ratio of 4.42%
Current Ratio0.12
Quick Ratio0.12
Debt to Market Cap0.78
Net Debt to EBITDA-5.59
Interest Coverage Ratio0.00
Taxes
In the past 12 months, THC Farmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.50
Enterprise Valuation
THC Farmaceuticals EV to EBITDA ratio is -12.84, with an EV/FCF ratio of 0.51.
EV to Sales0.00
EV to EBITDA-12.84
EV to Free Cash Flow0.51
EV to Operating Cash Flow0.51
Balance Sheet
THC Farmaceuticals has $6.87K in cash and marketable securities with $386.30K in debt, giving a net cash position of -$379.43K billion.
Cash & Marketable Securities$6.87K
Total Debt$386.30K
Net Cash-$379.43K
Net Cash Per Share-$0.02
Tangible Book Value Per Share$0.05
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for THC Farmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―